Great Point Partners
GOSS icon

Great Point Partners’s Gossamer Bio GOSS Stock Holding History

Great Point Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-77,878
Closed -$5.19M – 40
2023
Q3 		$5.19M Buy
+77,878
New +$7.18M 0.95% 30

Other funds holding GOSS

NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Platinum Investment Management
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Eversept Partners
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Great Point Partners's GOSS Position: Q4 2023 in Review

Great Point Partners sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 77,878 shares — an estimated $5.19M sold.

Great Point Partners first reported a position in GOSS in Q3 2023 and held it in 1 quarter. The position peaked at $5.19M in Q3 2023. 96 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Great Point Partners reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Great Point Partners sold 77,878 Gossamer Bio shares in Q4 2023, an estimated $5.19M.
  • Great Point Partners first reported a position in Gossamer Bio in Q3 2023 and held it in 1 quarter.
  • Great Point Partners's Gossamer Bio position peaked at $5.19M in Q3 2023.
  • 96 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Great Point Partners's 13F filing for Q4 2023, filed 14 Feb 2024.